Katarzyna Dzitko

11PUBLICATIONS
24CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyBiomolecular modelling and designMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 16, 2025
Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect.

Agata Paneth, Katarzyna Dzitko, Adrian Bekier

|May 25, 2024
Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine-Hydrazide Hydrazone Derivative.

Joanna Wasiak, Pola Głowacka, Agnieszka Pudlarz

|Feb 11, 2023
TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents.

Katarzyna Dzitko, Barbara Kaproń, Agata Paneth

|Sep 27, 2022
Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.

Lidia Węglińska, Adrian Bekier, Nazar Trotsko

|Mar 25, 2022
4-Arylthiosemicarbazide Derivatives as Toxoplasmic Aromatic Amino Acid Hydroxylase Inhibitors and Anti-inflammatory Agents.

Adrian Bekier, Anna Brzostek, Agata Paneth

|Dec 24, 2021
Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity.

Adrian Bekier, Malwina Kawka, Jakub Lach

Pageof 2

Frequent Collaborators

7 joint publications

Adrian Bekier

5 joint publications

Agata Paneth

4 joint publications

Justyna Gatkowska

4 joint publications

Piotr Paneth